Scaffold Diversity Analysis of Compound Data Sets Using an Entropy-Based Measure

Scaffold diversity analysis of compound databases has multiple applications in medicinal chemistry and drug discovery including library design, compounds acquisition, virtual screening and assessment of structure-activity-relationships. The scaffold diversity is commonly measured based on frequency counts. Further information can be obtained by considering the specific distribution of the molecules in those scaffolds. To this end, we introduce in this work the use of an entropy-based information metric to assess the scaffold diversity of compound data sets. As a test case we analyzed the scaffold diversity of 16 data sets of active compounds comparable in size targeting five protein classes of interest in drug design. The diversity was also assessed in terms of frequency counts and scaffold retrieval curves. The entropy-based information metric takes into account the frequency distribution of the different scaffolds and is a complementary measure of scaffold diversity enabling a more comprehensive analysis.

[1]  G. Bemis,et al.  The properties of known drugs. 1. Molecular frameworks. , 1996, Journal of medicinal chemistry.

[2]  Alban Arrault,et al.  Managing, profiling and analyzing a library of 2.6 million compounds gathered from 32 chemical providers , 2006, Molecular Diversity.

[3]  Gisbert Schneider,et al.  Properties and Architecture of Drugs and Natural Products Revisited , 2007 .

[4]  Tudor I. Oprea,et al.  Scaffold Topologies. 2. Analysis of Chemical Databases , 2008, J. Chem. Inf. Model..

[5]  Andrew C. Good,et al.  Measuring CAMD technique performance: A virtual screening case study in the design of validation experiments , 2004, J. Comput. Aided Mol. Des..

[6]  Mark Johnson,et al.  Algorithm for Naming Molecular Equivalence Classes Represented by Labeled Pseudographs , 2001, J. Chem. Inf. Comput. Sci..

[7]  P. Jaccard,et al.  Etude comparative de la distribution florale dans une portion des Alpes et des Jura , 1901 .

[8]  Andreas Bender,et al.  “Plate Cherry Picking”: A Novel Semi-Sequential Screening Paradigm for Cheaper, Faster, Information-Rich Compound Selection , 2007, Journal of biomolecular screening.

[9]  Rajarshi Guha,et al.  Chemoinformatic Analysis of Combinatorial Libraries, Drugs, Natural Products, and Molecular Libraries Small Molecule Repository , 2009, J. Chem. Inf. Model..

[10]  Gerald M. Maggiora,et al.  Hierarchical Strategy for Identifying Active Chemotype Classes in Compound Databases , 2006, Chemical biology & drug design.

[11]  R. Glen,et al.  Molecular similarity: a key technique in molecular informatics. , 2004, Organic & biomolecular chemistry.

[12]  Gisbert Schneider,et al.  Scaffold diversity of natural products: inspiration for combinatorial library design. , 2008, Natural product reports.

[13]  Mark Johnson,et al.  Using Molecular Equivalence Numbers To Visually Explore Structural Features that Distinguish Chemical Libraries , 2002, J. Chem. Inf. Comput. Sci..

[14]  Andreas Bender,et al.  Similarity Searching of Chemical Databases Using Atom Environment Descriptors (MOLPRINT 2D): Evaluation of Performance , 2004, J. Chem. Inf. Model..

[15]  G. Schneider,et al.  Scaffold‐Hopping Potential of Ligand‐Based Similarity Concepts , 2006, ChemMedChem.

[16]  Nathan Brown,et al.  On scaffolds and hopping in medicinal chemistry. , 2006, Mini reviews in medicinal chemistry.

[17]  A. Schuffenhauer,et al.  Charting biologically relevant chemical space: a structural classification of natural products (SCONP). , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[18]  A. H. Lipkus,et al.  Structural Diversity of Organic Chemistry. a Scaffold Analysis of the Cas Registry , 2022 .

[19]  Stefan Wetzel,et al.  The Scaffold Tree - Visualization of the Scaffold Universe by Hierarchical Scaffold Classification , 2007, J. Chem. Inf. Model..

[20]  Andreas Bender,et al.  Diversity-oriented synthesis; a spectrum of approaches and results. , 2008, Organic & biomolecular chemistry.

[21]  Didier Rognan,et al.  Assessing the Scaffold Diversity of Screening Libraries , 2006, J. Chem. Inf. Model..

[22]  Jun Xu A new approach to finding natural chemical structure classes. , 2002, Journal of medicinal chemistry.

[23]  Wolfgang H. B. Sauer,et al.  Size doesn't matter: Scaffold diversity shape diversity, and biological activity of combinatorial libraries , 2003 .

[24]  J. Bajorath,et al.  Distribution of Molecular Scaffolds and R-Groups Isolated from Large Compound Databases , 1999 .

[25]  J. Mason,et al.  New 4-point pharmacophore method for molecular similarity and diversity applications: overview of the method and applications, including a novel approach to the design of combinatorial libraries containing privileged substructures. , 1999, Journal of medicinal chemistry.

[26]  Thomas Scior,et al.  Large compound databases for structure-activity relationships studies in drug discovery. , 2007, Mini reviews in medicinal chemistry.

[27]  B. E. Evans,et al.  Methods for drug discovery: development of potent, selective, orally effective cholecystokinin antagonists. , 1988, Journal of Medicinal Chemistry.

[28]  Schmid,et al.  "Scaffold-Hopping" by Topological Pharmacophore Search: A Contribution to Virtual Screening. , 1999, Angewandte Chemie.

[29]  J. Irwin,et al.  Benchmarking sets for molecular docking. , 2006, Journal of medicinal chemistry.

[30]  Andreas Bender,et al.  How Similar Are Similarity Searching Methods? A Principal Component Analysis of Molecular Descriptor Space , 2009, J. Chem. Inf. Model..

[31]  Gisbert Schneider,et al.  Collection of bioactive reference compounds for focused library design , 2003 .

[32]  James L. Melville,et al.  Better than Random? The Chemotype Enrichment Problem , 2009, J. Chem. Inf. Model..